Obesity

Showing   of 11 results

Collage of images depicting artificial intelligence.

How AI and the Built Environment Are Redefining Obesity Risk

UH Research & Education Institute

Fat cells, adipocyte and lipocyte, cholesterol in a cells

From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care

Ian Neeland, MD, explains how incretin therapies are improving outcomes in cardiovascular, metabolic, and related conditions, while exploring mechanisms, muscle preservation, and strategies for long-term success.

Illustration of endotracheal intubation on scientific background.

Improving Risk Stratification for Critically Ill Patients with Obesity

Innovations in Pulmonology, Critical Care & Sleep Medicine | Summer 2025

Doctor holding ipad with word obesity and heart rhythm displayed.

Multidisciplinary Approaches to Obesity Management

Innovations in Diabetes & Metabolic Care | Summer 2025

GLP-1 related drugs newspaper headlines with hand and magnifying glass.

Pharmacotherapy in Obesity Management

Innovations in Diabetes & Metabolic Care | Summer 2025

Gloved medical hands holding genetic food chain depicting science and food.

Nutritional Counseling Is an Essential Pillar of Obesity Management

Innovations in Diabetes & Metabolic Care | Summer 2025

Varun Sandaram, MD, PhD, MSc UH Harrington Heart & Vascular Institute

University Hospitals-led Study Highlights Potential Role for GLP-1RA in Secondary Prevention of AF

Innovations in Cardiovascular Medicine & Surgery | May 2025

Obesity control - scale with stethoscope

Structuring Care Around Obesity

Innovations in Diabetes & Endocrinology | Fall 2022

Results are loading...